Document Detail


Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A.
MedLine Citation:
PMID:  18955325     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
High morbidity and mortality associated with oral squamous cell carcinoma (OSCC) are largely attributable to late stage diagnosis. Despite significant advances in therapeutic strategies, the five-year survival rate for oral cancer remains at about 50%. A chemopreventive approach may be an effective alternative or adjunct to current therapies. Previous studies have shown anti-tumor effects of isoflavones in several cancers, including oral cancer. However, their mechanisms of action are still unclear. We hypothesized that isoflavones inhibit multiple signaling pathways implicated in oral carcinogenesis. To address our hypothesis, we investigated the effects of three isoflavone derivatives, genistein, biochanin A and daidzein, on SCC15 and SCC25 squamous cell carcinoma cell lines. In cell proliferation experiments, we found that genistein and biochanin A inhibited SCC15 and SCC25 cell growth with an IC50 of 50 μM. We also investigated the effect of isoflavones on ERK and Akt pathways. Our results, from western blot analysis, suggest that both genistein and biochanin A induced decreases in phosphorylation of ERK and Akt at treatment concentrations of 20, 50 and 100 μM. Taken together, our results clearly demonstrate a differential regulation of signaling pathways by various isoflavones in OSCC cell lines. Thus, tumor progression models can be utilized to study the preventive and therapeutic roles of isoflavones in oral cancer cell lines.
Authors:
Tara L Johnson; Maria B Lai; James C K Lai; Alok Bhushan
Related Documents :
500875 - Syringometaplasia: mucinous and squamous variants.
15569375 - Esophageal papillomatosis complicated by squamous cell carcinoma in situ.
21042725 - Cellular response to cetuximab in pten-silenced head and neck squamous cell carcinoma c...
7102765 - Some epidemiologic aspects of carcinoma of the vulva in israel.
21157935 - Collective cell migration of the cephalic neural crest: the art of integrating informat...
15037305 - Variations on a theme: the many modes of cytokinesis.
Publication Detail:
Type:  Journal Article     Date:  2008-02-29
Journal Detail:
Title:  Evidence-based complementary and alternative medicine : eCAM     Volume:  7     ISSN:  1741-4288     ISO Abbreviation:  Evid Based Complement Alternat Med     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2011-05-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101215021     Medline TA:  Evid Based Complement Alternat Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  351-8     Citation Subset:  -    
Affiliation:
Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy and Biomedical Research Institute, Idaho State University, Pocatello, Idaho, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patient...
Next Document:  Prognostic ability of practitioners of traditional arabic medicine: comparison with Western methods ...